Efficacy and Safety of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Post-Reception: A Meta-analysis
Nadeem Ashraf, Wajahat Akram & Kun Li · International Research Journal of Gastroenterology and Hepatology · 2025
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Although curative treatments such as surgical resection and liver transplantation offer potential for long-term survival, recurrence remains a significant challenge. Immune checkp...
Open access
Research Article
10.9734/irjgh/2025/v8i1122